Jump to content

Martin Zenke: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
FrescoBot (talk | contribs)
m Bot: link syntax/spacing and minor changes
Boissière (talk | contribs)
References: Corrected red-linked cat
Line 63: Line 63:
[[Category:1953 births]]
[[Category:1953 births]]
[[Category:Living people]]
[[Category:Living people]]
[[Category:German scientist]]
[[Category:German biochemists]]
[[Category:Stem cell researchers]]
[[Category:Stem cell researchers]]

Revision as of 09:13, 17 August 2012

Martin Zenke
Born (1953-08-07) August 7, 1953 (age 71)
NationalityGerman
Scientific career
Fieldsstem cell research, tissue engineering
InstitutionsRheinisch-Westfälische Technische Hochschule (RWTH) Medical School, Aachen, Germany. Helmholtz-Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany.

Martin Zenke born August 7 1953 in Korbach is a German biochemist und cell biologist, Professor for Cell Biology and scientist, who is conducting research on stem cells and biomedical engineering.

Biography

Martin Zenke grew up in Korbach/Waldeck, Germany and finished school at Alte Landesschule in Korbach in 1972. He studied chemistry/biochemistry and medicine at Philipps-University, Marburg/Lahn, Germany (1972-1978) and graduated in 1978 with a study on “The ribonucleotide reductase in synchronized cultures of Saccharomyces cerevisiae (baker’s yeast)”.

Professional Career

In 1979 he moved to German Cancer Research Center (DKFZ), Heidelberg, Institute of Virology, Section DNA Tumor Viruses (Gerhard Sauer) for doctoral studies[1]. He received his PhD from Ruprecht-Karls-University, Heidelberg in 1982 on “Transcription of SV40 Chromatin”[2].

From 1982 to 1985 Martin Zenke worked as postdoctoral fellow with Pierre Chambon at Université Louis Pasteur, Faculté de Médecine and Laboratoire de Genetique Moleculaire des Eucaryotes (LGME) in Strasbourg, France[3][4]. From 1985 to 1988 he was EMBL fellow[5] in the Differentiation Programme of European Molecular Biology Laboratory (EMBL), Heidelberg, Germany with Thomas Graf and Hartmut Beug[6].

In 1988 he moved to Institute of Molecular Pathology (IMP), Vienna, Austria to work as a Junior Scientist until 1995[7][8][9]. In 1992 he received his senior lecture qualification in Molecular Genetics from the Faculty of Natural Sciences, University of Vienna, Vienna, Austria. From 1995 to 2003 Martin Zenke was a Research Group Leader at Max Delbrück Center for Molecular Medicine (MDC) in Berlin, Germany[10].

Since 2003 he is Professor of Cell Biology and Chairman, and the founding director of the Institute for Biomedical Engineering, Chair of Cell Biology at Rheinisch-Westfälische Technische Hochschule (RWTH) Medical School, Aachen, Germany[11][12]. Since 2008 he is member of the "Central Ethics Committee for Stem Cell Research", Federal Ministry of Education and Research (BMBF) and Federal Ministry of Health (BMG), Berlin, Germany and since 2011 Managing Director of Helmholtz-Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany.

Main Research

Martin Zenke’s research focuses on the transcriptional regulation of gene expression. In 1986 he and his colleagues showed that transcriptional enhancers exhibit a modular structure and are composed of individual elements, which on their own are rather weak but act in synergy, and thereby build up enhancer activity. In 1988 Martin Zenke started to work on retroviral oncogenes, in particular on the v-erbA and v-rel oncogenes. His laboratory constructed a series of oncogenes that could be switched on and off at will. These conditional oncogenes were used to study differentiation of hematopoietic progenitor cells into red blood cells and antigen presenting dendritic cells.

In following up on this work the Zenke laboratory now focuses on stem cells, in particular on hematopoietic stem cells and their differentiated progeny. Current work also includes studies on embryonic stem cells and reprogramming of somatic cells towards pluripotency (cellular engineering) and on tissue engineering[13].

Publications

References

  1. ^ Zenke, M (1982 Aug 11). "Spliced and unspliced virus specific RNA sequences are associated with purified simian virus 40 chromatin". Nucleic Acids Research. 10 (15): 4543–50. doi:10.1093/nar/10.15.4543. PMID 6290985. {{cite journal}}: Check date values in: |date= (help); Unknown parameter |coauthors= ignored (|author= suggested) (help)
  2. ^ Zenke, Martin (1982). Transkription von SV40 Chromatin (in German). Frankfurt, Signatur: H 90b/9811: Heidelberg, Univ., Diss., 1982. p. 118.{{cite book}}: CS1 maint: location (link)
  3. ^ Zenke, M (1986 Feb). "Multiple sequence motifs are involved in SV40 enhancer function". The EMBO Journal. 5 (2): 387–97. PMC 1166744. PMID 3011406. {{cite journal}}: Check date values in: |date= (help); Unknown parameter |coauthors= ignored (|author= suggested) (help)
  4. ^ Davidson, I (1986 Oct 9-15). "Cell-type specific protein binding to the enhancer of simian virus 40 in nuclear extracts". Nature. 323 (6088): 544–8. doi:10.1038/323544a0. PMID 3020434. {{cite journal}}: Check date values in: |date= (help); Unknown parameter |coauthors= ignored (|author= suggested) (help)
  5. ^ Zenke, Martin. "EMBL Alumni". Retrieved 26 April 2012.
  6. ^ Zenke, M (1988 Jan 15). "v-erbA specifically suppresses transcription of the avian erythrocyte anion transporter (band 3) gene". Cell. 52 (1): 107–19. doi:10.1016/0092-8674(88)90535-1. PMID 2830979. {{cite journal}}: Check date values in: |date= (help); Unknown parameter |coauthors= ignored (|author= suggested) (help)
  7. ^ Institut für Molekulare Pathologie (IMP)
  8. ^ Zenke, M (1990 Jun 15). "v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA". Cell. 6. 61 (6): 1035–49. doi:10.1016/0092-8674(90)90068-P. PMID 1972036. {{cite journal}}: |access-date= requires |url= (help); Check date values in: |date= (help); Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)CS1 maint: date and year (link)
  9. ^ Boehmelt, G (1995 Jan 27). "Dendritic cell progenitor is transformed by a conditional v-Rel estrogen receptor fusion protein v-RelER". Cell. 80 (2): 341–52. doi:10.1016/0092-8674(95)90417-4. PMID 7834754. {{cite journal}}: Check date values in: |date= (help); Unknown parameter |coauthors= ignored (|author= suggested) (help)
  10. ^ Hacker, C (2003 Apr). "Transcriptional profiling identifies Id2 function in dendritic cell development". Nature immunology. 4 (4): 380–6. doi:10.1038/ni903. PMID 12598895. {{cite journal}}: Check date values in: |date= (help); Unknown parameter |coauthors= ignored (|author= suggested) (help)
  11. ^ Zenke, Martin. "Dr. Martin Zenke nimmt Ruf auf C4-Professur in Aachen an". public relations department of the Max Delbrück Center for Molecular Medicine. Retrieved 26 April 2012.
  12. ^ Zenke, Martin. "currently appointed professors RWTH 2003". RWTH Aachen. Retrieved 26 April 2012.
  13. ^ Zenke, Martin. "RWTH professor Martin Zenke publishes in Nature". public relations department RWTH Aachen. Retrieved 26 April 2012.

Template:Persondata